À propos
TNG
Head of the Clinical Pharmacology & Pharmacovigilance Department
Olivier BLIN (MD, PhD, MBA), is Professor of Pharmacology at Aix-Marseille University, certified in Neurology, Psychiatry and Medical Biology. He owns a PhD in Human Biology as well as a MBA from Ecole Centrale Paris. He is currently Head of the Clinical Pharmacology & Pharmacovigilance Department, Marseille University Hospital (Ap-Hm), member of UMR AMU-INSERM 1106, and coordinator of the University Hospital Federation DHUNE, COEN center on neurodegenerative disorders and aging (www.dhune.org). At the national level, he is a Member of the Working Group French National Plan for Rare Diseases, Member of the National Steering Committee French National Plan for Neurodegenerative Diseases and of the scientific committee of CNS ITMO Aviesan. He also is Vice President of the scientific council of CSFRS (Ecole Militaire, Paris).
Publications
- Neural correlates of β-lactam exposure in intensive care unit patients: an observational, prospective cohort study — Journal of Neurology, 2025
- Physiologically Based Pharmacokinetic Model of Cefotaxime in Patients with Impaired Renal Function — Clinical Pharmacokinetics, 2025
- Antibiotic-induced neurological adverse drug reactions — Therapies, 2024
- Cannabidiol and pharmacokinetics drug-drug interactions: Pharmacological toolbox — Therapies, 2024
- Towards precision dosing in psychiatry: Population pharmacokinetics meta-modelling of clozapine and lithium — Journal of Psychopharmacology, 2024
- β-Lactam Pharmacokinetic/Pharmacodynamic Target Attainment in Intensive Care Unit Patients: A Prospective, Observational, Cohort Study — Antibiotics, 2023